liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMI
Karolinska Inst, Sweden.
Uppsala Univ, Sweden.
Uppsala Univ, Sweden.
Karolinska Inst, Sweden.
Show others and affiliations
2024 (English)In: European Heart Journal - Cardiovascular Pharmacotherapy, ISSN 2055-6837, E-ISSN 2055-6845, Vol. 10, no 8, p. 708-718Article in journal (Refereed) Published
Abstract [en]

Aims In the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) study, long-term beta-blocker use in patients after acute myocardial infarction (AMI) with preserved left ventricular ejection fraction demonstrated no effect on death or cardiovascular outcomes. The aim of this prespecified substudy was to investigate effects of beta-blockers on self-reported quality of life and well-being. Methods and results From this parallel-group, open-label, registry-based randomized clinical trial, EQ-5D, and World Health Organization well-being index-5 (WHO-5) questionnaires were obtained at 6-10 weeks and 11-13 months after AMI in 4080 and 806 patients, respectively. We report results from intention-to-treat and on-treatment analyses for the overall population and relevant subgroups using Wilcoxon rank sum test and adjusted ordinal regression analyses. Of the 4080 individuals reporting EQ-5D (median age 64 years, 22% female), 2023 were randomized to beta-blockers. The main outcome, median EQ-5D index score, was 0.94 [interquartile range (IQR) 0.88, 0.97] in the beta-blocker group, and 0.94 (IQR 0.88, 0.97) in the no-beta-blocker group 6-10 weeks after AMI, OR 1.00 [95% CI 0.89-1.13; P > 0.9]. After 11-13 months, results remained unchanged. Findings were robust in on-treatment analyses and across relevant subgroups. Secondary outcomes, EQ-VAS and WHO-5 index score, confirmed these results. Conclusion Among patients after AMI with preserved left ventricular ejection fraction, self-reported quality of life and well-being was not significantly different in individuals randomized to routine long-term beta-blocker therapy as compared to individuals with no beta-blocker use. These results appear consistent regardless of adherence to randomized treatment and across subgroups which emphasizes the need for a careful individual risk-benefit evaluation prior to initiation of beta-blocker treatment.

Place, publisher, year, edition, pages
Oxford University Press, 2024. Vol. 10, no 8, p. 708-718
Keywords [en]
AMI: Acute myocardial infarction; EQ-VAS: EuroQoL visual analogue scale; EQ-5D: EuroQoL 5-dimension; LVEF: Left ventricular ejection fraction; QoL: Quality of life; SWEDEHEART: Swedish Web System for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies; WHO-5: World Health Organization-5
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:liu:diva-207430DOI: 10.1093/ehjcvp/pvae062ISI: 001302917600001PubMedID: 39217445OAI: oai:DiVA.org:liu-207430DiVA, id: diva2:1896174
Note

Funding Agencies|Swedish Heart Lung Foundation [2018:32, 2019:7, 2020:6, 20210216, 20180187, 20210273]; Region Stockholm [2018-0490, FoUI-974540]; Heart and Lung Association [2020:6, 2018:32, 2019:7]; Swedish Research Council [2009-1093]

Available from: 2024-09-09 Created: 2024-09-09 Last updated: 2025-04-19

Open Access in DiVA

fulltext(1210 kB)153 downloads
File information
File name FULLTEXT01.pdfFile size 1210 kBChecksum SHA-512
f1ef9350de28a50a2f2982eb79a2cc4880308231a806830cfa54711cf122d3aba2bc5cbcaad75543e1b1759fa7ca7e52d6437e01183bf09f97ba68e037b470bb
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Alfredsson, Joakim
By organisation
Division of Diagnostics and Specialist MedicineFaculty of Medicine and Health SciencesDepartment of Cardiology in Linköping
In the same journal
European Heart Journal - Cardiovascular Pharmacotherapy
Cardiology and Cardiovascular Disease

Search outside of DiVA

GoogleGoogle Scholar
Total: 154 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 90 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf